U.S. Markets close in 6 hrs 5 mins
  • S&P 500

    3,915.92
    -9.51 (-0.24%)
     
  • Dow 30

    31,924.18
    -37.68 (-0.12%)
     
  • Nasdaq

    13,549.57
    -48.40 (-0.36%)
     
  • Russell 2000

    2,288.38
    +4.00 (+0.18%)
     
  • Crude Oil

    63.07
    -0.15 (-0.24%)
     
  • Gold

    1,785.80
    -12.10 (-0.67%)
     
  • Silver

    28.09
    +0.16 (+0.58%)
     
  • EUR/USD

    1.2241
    +0.0073 (+0.5998%)
     
  • 10-Yr Bond

    1.4440
    +0.0550 (+3.96%)
     
  • Vix

    22.10
    +0.76 (+3.56%)
     
  • GBP/USD

    1.4174
    +0.0033 (+0.2310%)
     
  • USD/JPY

    106.0710
    +0.1890 (+0.1785%)
     
  • BTC-USD

    50,922.83
    +1,234.70 (+2.48%)
     
  • CMC Crypto 200

    1,018.70
    +24.04 (+2.42%)
     
  • FTSE 100

    6,679.96
    +20.99 (+0.32%)
     
  • Nikkei 225

    30,168.27
    +496.57 (+1.67%)
     

BIOLASE, Inc. to Report Third Quarter 2020 Results on November 12, 2020

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

FOOTHILL RANCH, Calif., Nov. 5, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2020 financial and operating results on Thursday, November 12, 2020 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (800) 367-2403. For international participants outside the U.S./Canada, the dial-in number is +1 334-777-6978. For all callers, refer to the Conference ID 9286776. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 259 patented and 41 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,500 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/biolase-inc-to-report-third-quarter-2020-results-on-november-12-2020-301166779.html

SOURCE BIOLASE, Inc.